PBYI vs TTWO · P/E 4.3, rev $56.5M vs rev $6.66B
Puma Biotechnology Inc (PBYI) versus Take-Two Interactive Software Inc (TTWO) — a side-by-side from cached financials, not a winner call.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Take-Two Interactive Software Inc (TTWO) is a electronic gaming & multimedia company listed on NASDAQ.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Latest reported TTWO revenue for 2026-03-31 was $6.66B. Net income was -$298.2M. Revenue was up 18.2% from 2025-03-31 to 2026-03-31. TTWO currently screens at market cap $42.34B.
PBYI currently screens at market cap $165.3M and trailing P/E 4.3. TTWO currently screens at market cap $42.34B.
Not investment advice. Open the PBYI and TTWO stock pages for the full models.
Not investment advice.